Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Sleep Medicine|August 8, 2013
Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover studyW Joseph Herring, Kenneth Liu, Jill Hutzelmann, et al.Journal of Alzheimer'S Disease : JAD|February 6, 2023
Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic TransitionsTiffini Voss, James Kost, Swati Pal Mercer, et al.Fertility and Sterility|September 11, 2024
Randomized, controlled, proof-of-concept trial of gefapixant for endometriosis-related painFelipe Arbelaez, Hee-Koung Joeng, Azher Hussain, et al.Neurology|December 1, 2012
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexantW Joseph Herring, Ellen Snyder, Kerry Budd, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 17, 2020
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trialW Joseph Herring, Paulette Ceesay, Ellen Snyder, et al.Respiratory Medicine|February 10, 2015
Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary diseaseHong Sun, John Palcza, Russell Rosenberg, et al.American Journal of Ophthalmology|February 8, 2012
Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertensionAlmira Chabi, Rohit Varma, James C Tsai, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 22, 2015
Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep ApneaHong Sun, John Palcza, Deborah Card, et al.Headache|April 5, 2011
Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraineDavid J Hewitt, Vincent Martin, Richard B Lipton, et al.Biological Psychiatry|October 27, 2005
Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorderMartin Keller, Stuart Montgomery, William Ball, et al.Pageof 6